Donald A. Broggi

Bio

Mr. Broggi is engaged in the Firm’s securities, antitrust, mass tort, and consumer litigation practices.  Mr. Broggi is a partner in the Firm’s New York office and has represented institutional investors, including public pension funds and Taft-union funds in a variety of complex cases, including: In re Foreign Exchange Benchmark Rates Antitrust Litigation, No. 1:13-cv-07789 (S.D.N.Y.): an antitrust class action alleging the world’s largest banks conspired to fix the price of foreign currencies ($2.3 billion in settlements to date); Alaska Elec. Pension Fund v. Bank of Am. Corp., No. 1:14-cv-07126 (S.D.N.Y.): an antitrust class action alleging the world’s largest banks conspired to manipulate the ISDAfix rate ($504.5 million settlement); Dahl v. Bain Capital Partners, No. 07-cv-12388 (D. Mass.): an antitrust class action alleging that the nation’s largest private equity firms, including KKR, Blackstone, TPG, Carlyle, Bain Capital, and Goldman Sachs, colluded to restrain competition and suppress prices paid to shareholders of public companies in connection with multi-billion dollar leveraged buyouts ($590.5 million settlement); In re GSE Bonds Antitrust Litigation, No. 19-cv-01704 (S.D.N.Y.): an antitrust class action alleging manipulation in the market for bonds issued by Government-Sponsored Entities, e.g., Freddie Mac and Fannie Mae ($386.5 million settlement pending final approval); Irvine v. ImClone Sys., Inc., No. 02-cv-00109 (S.D.N.Y.): a securities fraud class action alleging that defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by issuing materially false and misleading statements to the market regarding the cancer drug Erbitux ($75 million settlement); In re Wash. Mut. Mortg.-Backed Sec. Litigation, No. 2:09-cv-00037 (W.D. Wash.): a securities fraud class action against Washington Mutual Bank alleging violations of §11 of the Securities Act for misleading investors about the quality of their mortgage-backed securities ($26 million settlement); In re SanDisk LLC Sec. Litigation, No. 15-cv-01455 (N.D. Cal.): a securities fraud class action alleging that defendants intentionally inflated the price of the Company’s stock by making false and misleading statements and concealing information relating to SanDisk’s business, operations, and prospects ($50 million settlement); and Arkansas Teacher Retirement System v. Insulet Corp., No. 15-cv-12345 (D. Mass.): a securities fraud class action alleging Insulet Corporation intentionally inflated the price of the Company’s stock by issuing false and misleading statements concerning Insulet’s launch of its new insulin infusion system, branded the OmniPod Eros ($19.5 million settlement), among others.